Finance

Lists
Why is 9606 up 10,89%?
Dive Deeper
9606:HKG
Duality Biotherapeutics Inc
170,00 HKD
+10,89%
(+16,70) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9606...
Open
154,50 HKD
High
179,60 HKD
Low
154,50 HKD
Mkt. cap
13,57 მლრდ.
Avg. vol.
770,17 ათ.
Volume
1,74 მლნ.
52-wk high
376,80 HKD
52-wk low
151,40 HKD
EPS
-18,69 HKD
No. of employees
266
Open
154,50 HKD
High
179,60 HKD
Low
154,50 HKD
Mkt. cap
13,57 მლრდ.
Avg. vol.
770,17 ათ.
Volume
1,74 მლნ.
52-wk high
376,80 HKD
52-wk low
151,40 HKD
EPS
-18,69 HKD
No. of employees
266
News stories
From web sources and news partners
TradingView
TradingView
·
1 საათის წინ
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
The Fintech Times
The Fintech Times
·
24 წუთის წინ
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
Bloomberg.com
·
4 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
About Duality Biotherapeutics Inc
CEO-
Employees266
Founded3 ივლ. 2019
Headquarters-
Sector-
Websitedualitybiologics.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
311,40 მლნ.
311,40 მლნ.
109,66 მლნ.
109,66 მლნ.
Cost of goods sold
311,55 მლნ.
311,55 მლნ.
226,34 მლნ.
226,34 მლნ.
Cost of revenue
311,55 მლნ.
311,55 მლნ.
226,34 მლნ.
226,34 მლნ.
Research and development expenses
244,19 მლნ.
244,19 მლნ.
303,33 მლნ.
303,33 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44,53 მლნ.
44,53 მლნ.
40,77 მლნ.
40,77 მლნ.
Operating expense
288,00 მლნ.
288,00 მლნ.
342,03 მლნ.
342,03 მლნ.
Total operating expenses
599,55 მლნ.
599,55 მლნ.
568,37 მლნ.
568,37 მლნ.
Operating income
-288,15 მლნ.
-288,15 მლნ.
-458,70 მლნ.
-458,70 მლნ.
Other non operating income
6,86 მლნ.
6,86 მლნ.
-
-
EBT including unusual items
-260,48 მლნ.
-260,48 მლნ.
-458,77 მლნ.
-458,77 მლნ.
EBT excluding unusual items
-264,12 მლნ.
-264,12 მლნ.
-459,70 მლნ.
-459,70 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-722,50 ათ.
-722,50 ათ.
-2,08 მლნ.
-2,08 მლნ.
Net income
-260,48 მლნ.
-260,48 მლნ.
-458,77 მლნ.
-458,77 მლნ.
Net profit margin
-83,65%
-83,65%
-418,34%
-418,34%
Earnings per share
-
-
-
-
Interest and investment income
29,92 მლნ.
29,92 მლნ.
25,95 მლნ.
25,95 მლნ.
Interest expense
-318,50 ათ.
-318,50 ათ.
-1,27 მლნ.
-1,27 მლნ.
Net interest expenses
29,60 მლნ.
29,60 მლნ.
24,68 მლნ.
24,68 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-286,03 მლნ.
-286,03 მლნ.
-456,26 მლნ.
-456,26 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები